Molecular Neurodegeneration

Title Publication Date Language Citations
Dominant optic atrophy, OPA1, and mitochondrial quality control: understanding mitochondrial network dynamics2013/01/01English90
Mitochondrial permeability transition pore induces mitochondria injury in Huntington disease2013/01/01English77
Transthyretin and the brain re-visited: Is neuronal synthesis of transthyretin protective in Alzheimer's disease?2011/01/01English76
Reduced axonal transport in Parkinson's disease cybrid neurites is restored by light therapy2009/01/01English68
Expression profiling in APP23 mouse brain: inhibition of Aβ amyloidosis and inflammation in response to LXR agonist treatment2007/01/01English65
The synaptic maintenance problem: membrane recycling, Ca2+ homeostasis and late onset degeneration2013/01/01English65
Does a loss of TDP-43 function cause neurodegeneration?2012/01/01English65
Neurodegeneration in Alzheimer's disease: caspases and synaptic element interdependence2009/01/01English58
Cross-talk of membrane lipids and Alzheimer-related proteins2013/01/01English58
Soluble amyloid-β, effect on cerebral arteriolar regulation and vascular cells2010/01/01English55
Combined exposure to Maneb and Paraquat alters transcriptional regulation of neurogenesis-related genes in mice models of Parkinson’s disease2012/01/01English55
Voluntary exercise protects against methamphetamine-induced oxidative stress in brain microvasculature and disruption of the blood–brain barrier2013/01/01English54
GSK3 and p53 - is there a link in Alzheimer's disease?2010/01/01English53
Novel rat Alzheimer's disease models based on AAV-mediated gene transfer to selectively increase hippocampal Aβ levels2007/01/0152
A hereditary spastic paraplegia mutation in kinesin-1A/KIF5A disrupts neurofilament transport2010/01/01English52
Presenilin-dependent intramembrane cleavage of ephrin-B12006/01/01English50
Nitrosamine exposure exacerbates high fat diet-mediated type 2 diabetes mellitus, non-alcoholic steatohepatitis, and neurodegeneration with cognitive impairment2009/01/01English50
Vascular endothelial growth factor B (VEGF-B) is up-regulated and exogenous VEGF-B is neuroprotective in a culture model of Parkinson's disease2009/01/01English46
Absence of dopaminergic neuronal degeneration and oxidative damage in aged DJ-1-deficient mice2007/01/0146
Heart fatty acid binding protein and Aβ-associated Alzheimer’s neurodegeneration2013/01/01English45
Ginkgolides protect against amyloid-β1–42-mediated synapse damage in vitro2008/01/01English45
Presenilins are required for maintenance of neural stem cells in the developing brain2008/01/01English45
What have worm models told us about the mechanisms of neuronal dysfunction in human neurodegenerative diseases?2009/01/01English43
Lysosomal function in macromolecular homeostasis and bioenergetics in Parkinson's disease2010/01/01English43
Chronic traumatic encephalopathy: clinical‐biomarker correlations and current concepts in pathogenesis2014/01/01English43
Simultaneous and independent detection of C9ORF72 alleles with low and high number of GGGGCC repeats using an optimised protocol of Southern blot hybridisation2013/01/01English42
Superoxide dismutase 1 encoding mutations linked to ALS adopts a spectrum of misfolded states2011/01/01English41
TDP-43 knockdown impairs neurite outgrowth dependent on its target histone deacetylase 62011/01/01English40
Epigenetic regulation of adult neural stem cells: implications for Alzheimer’s disease2014/01/01English39
BBC3 (PUMA) regulates developmental apoptosis but not axonal injury induced death in the retina2011/01/01English38